Status:
TERMINATED
Evaluation of the Safety of Sepraspray in Open Abdominal Surgery
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Adhesion Prevention (Abdominal)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the Performance of Sepraspray in Patients undergoing open abdominal surgery NOTE regarding reason for study termination: A patient death reported during the trial warranted t...
Eligibility Criteria
Inclusion
- Patients 18 years old and over that require open abdominal surgery
Exclusion
- Patients who are pregnant or have ongoing abdominal abscess or bacterial peritonitis or have infectious complications from a previous laparectomy
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00778479
Start Date
October 1 2008
End Date
May 1 2009
Last Update
March 24 2015
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Hotel Dieu
Clamond, France
2
CHRU de Lille, Hopital Huriez
Lille, France
3
Hopital de la Croix Rousse
Lyon, France
4
Hopital Lariboisiere
Paris, France